CytoMed Therapeutics Limited Ordinary Shares
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|
Revenue | $130 | $105 | $100 |
Gross Profit | -432 | 98 | 93 |
EBITDA | -1,730 | -804 | -761 |
EBIT | -1,832 | -874 | -828 |
Net Income | -1,346 | -882 | -835 |
Net Change In Cash | 130 | 105 | 100 |
Free Cash Flow | -1,825 | -765 | -724 |
Cash | 2,095 | 2,245 | 2,125 |
Basic Shares | 11,788 | 11,809 | 11,809 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $248 | $52 | $290 | $270 |
Gross Profit | -689 | 52 | 381 | -81 |
EBITDA | -3,341 | -1,790 | -2,937 | -1,095 |
EBIT | -3,515 | -1,882 | -3,015 | -1,388 |
Net Income | -3,046 | -1,883 | -3,131 | -2,270 |
Net Change In Cash | 248 | 52 | 290 | 270 |
Free Cash Flow | -4,400 | -3,009 | -2,720 | -1,397 |
Cash | 2,095 | 3,639 | 6,816 | 1,179 |
Basic Shares | 11,647 | 11,539 | 10,630 | 7,915 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-09-30 | -$0.19 |
2025-03-31 | -$0.12 |
2024-09-30 | -$0.04 |
